| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $57,113,320 ) (Continued on the next page) |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI185102 | Development of broadly neutralizing human monoclonal antibodies against henipaviruses | 000 | 2 | NIH | 1/30/2026 | $830,098 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AR080616 | Engineered Asymmetric Hydrogel for Muscle Stem Cell Polarity and Fate Specification | 000 | 5 | NIH | 1/21/2026 | $409,831 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI168178 | Structural interrogation of vaccine- and infection-induced B cell responses | 000 | 5 | NIH | 1/6/2026 | $780,825 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI170596 | Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2 | 000 | 4 | NIH | 1/27/2026 | $852,747 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI163011 | Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization | 000 | 5 | NIH | 2/5/2026 | $545,212 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG096298 | The risk of Alzheimer's disease and related dementias among individuals with Autism Spectrum Disorder (AsDRD) | 000 | 1 | NIH | 2/6/2026 | $575,377 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG087324 | Leveraging large-scale genomics to dissect A-to-I editing in brain aging and Alzheimer's disease | 000 | 3 | NIH | 1/23/2026 | $508,112 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG072489 | Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease | 000 | 5 | NIH | 12/18/2025 | $1,057,227 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R00DK140517 | Deciphering the role of phospholipid homeostasis in physiology and disease | 000 | 3 | NIH | 1/29/2026 | $249,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R00HD108392 | Disruption of three-dimensional genome organization as a noncoding mechanism of disease in human developmental disorders | 000 | 4 | NIH | 1/12/2026 | $223,044 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135728 | Investigating the Neurobiology of Early Cognitive Impairment | 000 | 3 | NIH | 1/14/2026 | $163,927 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 000 | 2 | NIH | 12/19/2025 | $573,253 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 001 | 2 | NIH | 1/13/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL162580 | Adaptive immunity regulates arteriovenous fistula remodeling | 000 | 5 | NIH | 2/9/2026 | $762,073 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH132786 | Dynamic Neural Computations Underlying Cognitive Control in Bulimia Nervosa | 000 | 4 | NIH | 12/5/2025 | $803,489 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH133625 | Neurocomputational mechanisms and connectivity dynamics underlying obsessive-compulsive disorder and phenotypical differentiations | 000 | 3 | NIH | 2/5/2026 | $844,081 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH132733 | Establishing the Suicide Working Group of the Psychiatric Genomics Consortium to elucidate the genetics and biology of suicide outcomes | 000 | 3 | NIH | 2/6/2026 | $831,477 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS060123 | Neuronal Autophagy: a Cell-Autonomous Protection Mechanism | 000 | 19 | NIH | 2/5/2026 | $606,559 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH134973 | Biophysical modeling as a translational bridge for understanding neural ensemble alterations in schizophrenia. | 000 | 3 | NIH | 2/4/2026 | $747,607 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH139940 | Pathophysiological mechanisms of cannabidiol in stress regulation | 000 | 2 | NIH | 1/27/2026 | $743,561 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH129372 | Functional mapping of noncoding regulatory variants in human neuronal subtypes3. | 000 | 5 | NIH | 1/27/2026 | $569,749 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH127315 | Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study | 000 | 5 | NIH | 2/4/2026 | $844,894 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH131655 | A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents with Low Weight Eating Disorders | 000 | 4 | NIH | 1/27/2026 | $782,443 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH129306 | Epigenetic Mechanisms of Chronic Stress Action | 000 | 4 | NIH | 12/9/2025 | $674,536 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH104559 | ROLE OF PERIPHERAL IMMUNE-DERIVED MMP8 IN STRESS SUSCEPTIBILITY | 000 | 13 | NIH | 12/9/2025 | $842,950 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH116900 | Molecular studies of neural histone monoaminylation in normal and aberrant brain plasticity | 000 | 8 | NIH | 12/22/2025 | $844,899 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG013350 | Systematic integration of variant interpretation tools into genetic and genomic risk prediction | 000 | 3 | NIH | 2/2/2026 | $618,303 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL136255 | Mitochondria in the Regulation of Terminal Erythropoiesis | 000 | 8 | NIH | 2/9/2026 | $506,749 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD092990 | Extracellular regulation of Xenopus development | 000 | 7 | NIH | 1/21/2026 | $475,118 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK129735 | Podocyte-specific Rap1 agonism for treatment of glomerular disease | 000 | 5 | NIH | 1/30/2026 | $618,264 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK131525 | Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV | 000 | 5 | NIH | 12/23/2025 | $841,127 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136016 | Hepatic stellate cell plasticity and maladaptive fibrogenic memory in chronic liver disease | 000 | 4 | NIH | 2/9/2026 | $592,181 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK134773 | Genetic Analysis of Intrinsic Sensory Neuron Function in the Enteric Neural Circuits | 000 | 4 | NIH | 1/29/2026 | $598,796 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035791 | Prenatal and infant household air pollution exposure, the human microbiome and virome, and childhood lung function: the GRAPHS randomized controlled trial | 001 | 2 | NIH | 1/29/2026 | $118,029 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035791 | Prenatal and infant household air pollution exposure, the human microbiome and virome, and childhood lung function: the GRAPHS randomized controlled trial | 000 | 2 | NIH | 1/27/2026 | $1,231,131 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 001 | 3 | NIH | 1/19/2026 | $69,858 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 000 | 3 | NIH | 1/13/2026 | $518,142 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES032552 | The interplay of early life exposure to environmental pollutants and folate system in the etiology of autistic behaviors | 000 | 5 | NIH | 12/30/2025 | $582,537 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EB035491 | Engineering pluripotent stem cells to evade and promote immunity | 000 | 3 | NIH | 12/9/2025 | $477,398 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES034864 | Cardiometabolic diseases in the World Trade Center general responder cohort and the role of subsequent environmental exposures | 000 | 4 | NIH | 1/21/2026 | $474,332 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK141891 | Manufacture of defined live microbial therapeutics for infectious and inflammatory disease | 000 | 2 | NIH | 1/19/2026 | $671,511 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136035 | Interleukin-10 mediated immune cell-adipocyte crosstalk in adipose thermogenesis | 000 | 3 | NIH | 1/16/2026 | $618,621 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 000 | 3 | NIH | 1/21/2026 | $331,100 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK137968 | The effects of a high fructose diet on the gut microbiome and metabolic health: A controlled clinical intervention study | 000 | 3 | NIH | 12/22/2025 | $729,507 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK138025 | microRNA-controlled mRNA therapeutics | 000 | 3 | NIH | 1/16/2026 | $559,205 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01AG073148 | A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | 000 | 5 | NIH | 1/6/2026 | $2,321,095 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | T32HL160511 | Multidisciplinary Research Training in Sleep Science | 000 | 4 | NIH | 1/31/2026 | $392,778 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA269982 | Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding | 001 | 4 | NIH | 1/20/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA269982 | Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding | 000 | 4 | NIH | 12/8/2025 | $468,806 |
|
